Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis

被引：0
|
作者：
Liebmann, M. [1 ]
Janoschka, C. [1 ]
Herrmann, A. [1 ]
Schulte-Mecklenbeck, A. [1 ]
Schwab, N. [1 ]
Gross, C. C. [1 ]
Koenig, S. [2 ]
Meuth, S. G. [1 ]
Wiendl, H. [1 ]
Klotz, L. [1 ]
机构：
[1] Univ Hosp Muenster, Inst Translat Neurol, Clin Neurol, Munster, Germany
[2] Univ Munster, Interdisciplinary Clin Res Ctr, Integrated Funct Genom, Munster, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1359
引用
收藏
页码：748 / 749
页数：2
相关论文
共 50 条
  • [41] Dimethyl fumarate alters the composition of B cells in the blood and cerebrospinal fluid of patients with multiple sclerosis
    Hoglund, R.
    Polak, J.
    Vartdal, F.
    Holmoy, T.
    Lossius, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 688 - 688
  • [42] Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis
    Yang, Bing
    Parker, Robert B.
    Meibohm, Bernd
    Temrikar, Zaid H.
    Srivastava, Ashish
    Laizure, S. Casey
    [J]. PLOS ONE, 2022, 17 (11):
  • [43] Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
    Longbrake, Erin E.
    Ramsbottom, Michael J.
    Cantoni, Claudia
    Ghezzi, Laura
    Cross, Anne H.
    Piccio, Laura
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (08) : 1061 - 1070
  • [44] Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets
    Lundy, Steven K.
    Wu, Qi
    Wang, Qin
    Dowling, Catherine A.
    Taitano, Sophina H.
    Mao, Guangmei
    Mao-Draayer, Yang
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (02):
  • [45] Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment
    Cunill, Vanesa
    Massot, Margarita
    Clemente, Antonio
    Calles, Carmen
    Andreu, Valero
    Nunez, Vanessa
    Lopez-Gomez, Antonio
    Maria Diaz, Rosa
    de los Reyes Jimenez, Maria
    Pons, Jaime
    Vives-Bauza, Cristofol
    Maria Ferrer, Joana
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [46] Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis
    Ferri, Caterina
    Castellazzi, Massimiliano
    Merli, Nicola
    Laudisi, Michele
    Baldin, Elisa
    Baldi, Eleonora
    Mancabelli, Leonardo
    Ventura, Marco
    Pugliatti, Maura
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [47] Dimethyl fumarate versus interferon for treatment of relapsing-remitting multiple Sclerosis
    Sattarnezhad, Neda
    Healy, Brian C.
    Baharnoori, Moogeh
    Diaz-Cruz, Camilo
    Stankiewicz, James
    Weiner, Howard L.
    Chitnis, Tanuja
    [J]. NEUROLOGY, 2017, 88
  • [48] Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects
    Linker, Ralf A.
    Gold, Ralf
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (11)
  • [49] COST EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE VERSUS TERIFLUNOMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Ruiz, L.
    Machado, L.
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Harrington, A.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A724 - A724
  • [50] Comparison of Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two Year Experience
    Vollmer, Brandi
    Nair, Kavita
    Sillau, Stefan
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    [J]. NEUROLOGY, 2016, 86
12345